Cited by 5Treatment of Major DepressionCardiac Health and Mental HealthMitochondrial Function and Pathology

The impacts of vorinostat on NADPH oxidase and mitochondrial biogenesis gene expression in the heart of mice model of depression

Nasehi, Leila, Morassaei, Bahareh, Ghaffari, Maryam, Sharafi, Ali, Dehpour, Ahmad Reza, Hosseini, Mir-Jamal·2022·Canadian Journal of Physiology and Pharmacology

Abstract

The comorbidity of depression and high risk of cardiovascular diseases (CVD) have been reported as major health problems. Our previous study confirmed that fluoxetine (FLX) therapy had a significant influence on brain function but not on the heart in depression. In the present study, suberoyanilide hydroxamic acid (SAHA) was proposed as another therapeutic candidate for treatment of depression comorbid CVD in maternal separation model, following behavioral analyses and gene expression level in the heart. Our data demonstrated that SAHA significantly attenuates the NOX-4 gene expression level in treated mice with SAHA and FLX without significant change in NOX-2 expression level. SAHA decreased the gene expression level of peroxisome proliferator-activated receptor-gamma coactivator (PGC-1α) and nuclear respiratory factors (Nrf2) in heart tissues of maternally separated mice. It supposed that non-effectiveness of FLX on mitochondrial biogenesis and NOX gene expression level in the heart of depressed patient can be related to recurrence of depression. It revealed that SAHA not only reversed the depressive-like behavior similar to our previous data but also recovered the heart mitochondrial function via effect on NOX-2, NOX-4, and mitochondrial biogenesis genes' (PGC-1 α, Nrf-2, and peroxisome proliferator-activated receptor- α (PPAR- α)) expression levels. We suggest performing more studies to confirm SAHA as a therapeutic candidate in depression comorbid CVD.

Integrity signals

Registry

Crossref · 10.1139/cjpp-2022-0098

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The broad-spectrum HDAC inhibitor SAHA exhibits antidepressant effects across multiple animal models, with benefits that extend beyond mood improvement.

    “The broad-spectrum HDAC inhibitor SAHA exhibits antidepressant effects across multiple animal models, with benefits that extend beyond mood improvement (Nasehi et al., 2022; Ershadi et al., 2021; Chen et al., 2019; Meylan et al., 2016).”
  • HDACs and HMTs regulate stress susceptibility, neural plasticity, cognitive function, and comorbid somatic conditions.

    “Preclinical studies consistently show that HDACs and HMTs regulate stress susceptibility, neural plasticity, cognitive function, and comorbid somatic conditions (Li et al., 2024; Nasehi et al., 2022; Ershadi et al., 2021).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Nasehi, L., Morassaei, B., Ghaffari, M., Sharafi, A., Dehpour, A. R., & Hosseini, M.-J.
Affiliations
  • Zanjan University of Medical Sciences (IR)
  • Tehran University of Medical Sciences (IR)
Venue
Canadian Journal of Physiology and Pharmacology
Published
2022-11-01
Volume
100
Issue
11
Pages
1077-1085
ISSN
  • 0008-4212 (ISSN-L)
  • 1205-7541
OpenAlex
W4297206781
Cited by
5
References
41
Citations by year
2026: 2 · 2025: 1 · 2024: 1 · 2023: 1
FWCI
0.45
Type
journal article
Language
en
Open access
closed
Locations
  • Canadian Journal of Physiology and Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Keywords
vorinostat, depression, cardiovascular comorbidity, maternal separation, NADPH oxidase, NOX4, NOX2, mitochondrial biogenesis, PGC-1α, Nrf2, PPARα, heart, fluoxetine, depression-like behavior, gene expression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review